Henry Schein Net Income/Loss 2012-2026 | HSIC
Henry Schein annual/quarterly net income/loss history and growth rate from 2012 to 2026. Net income/loss can be defined as the company's total income or loss before preferred stock dividends, taken from the Income Statement
- Henry Schein net income/loss for the quarter ending March 31, 2026 was $419M, a 5.28% increase year-over-year.
- Henry Schein net income/loss for the twelve months ending March 31, 2026 was $1.055B, a 5.39% increase year-over-year.
- Henry Schein annual net income/loss for 2025 was $0.419B, a 5.28% increase from 2024.
- Henry Schein annual net income/loss for 2024 was $0.398B, a 8.72% decline from 2023.
- Henry Schein annual net income/loss for 2023 was $0.436B, a 22.97% decline from 2022.
|
Henry Schein Annual Net Income/Loss (Millions of US $) |
|
|---|---|
| 2025 | $419 |
| 2024 | $398 |
| 2023 | $436 |
| 2022 | $566 |
| 2021 | $660 |
| 2020 | $420 |
| 2019 | $719 |
| 2018 | $562 |
| 2017 | $459 |
| 2016 | $556 |
| 2015 | $523 |
| 2014 | $505 |
| 2013 | $471 |
| 2012 | $423 |
| 2011 | $405 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $8.645B | $13.184B |
| Henry Schein Inc. is a leading distributor of health care products and services across the globe. The company serves office-based dental, medical and animal health practitioners, dental laboratories, government as well as institutional health care clinics and other alternate-care sites. Henry Schein's 3 businesses - Dental, Medical and Technology and Value-Added Services serve millions of customers worldwide. Henry Schein has completed the spinoff of its global Animal Health business. The global dental group serves office-based dental practitioners, dental laboratories, schools and other institutions. The global medical group serves office-based medical practitioners, ambulatory surgery centers, other alternate-care settings and other institutions. The global technology and value-added services group provides software, technology and other value-added services to health care practitioners. The technology group offerings include practice management software systems for dental and medical practitioners. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $106.025B | 23.03 |
| Cardinal Health (CAH) | United States | $50.715B | 22.43 |
| Becton Dickinson (BDX) | United States | $43.913B | 11.10 |
| West Pharmaceutical Services (WST) | United States | $18.493B | 35.19 |
| Straumann Holding AG (SAUHY) | Switzerland | $16.902B | 0.00 |
| Cooper (COO) | United States | $13.894B | 16.52 |
| Align Technology (ALGN) | United States | $12.400B | 21.09 |
| Merit Medical Systems (MMSI) | United States | $4.072B | 19.84 |
| DENTSPLY SIRONA (XRAY) | United States | $2.339B | 7.36 |
| STAAR Surgical (STAA) | United States | $1.309B | 0.00 |
| CONMED (CNMD) | United States | $1.107B | 7.97 |
| Pro-Dex (PDEX) | United States | $0.165B | 19.65 |
| Lifevantage (LFVN) | United States | $0.053B | 5.46 |
| Axe Compute (AGPU) | United States | $0.022B | 0.00 |